Prostate cancer management costs vary by disease stage at presentation

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1

References

  1. 1.

    Cutler DM, Ghosh K. The potential for cost savings through bundled episode payments. N Engl J Med. 2012;366:1075–7.

    CAS  Article  Google Scholar 

  2. 2.

    Trogdon JG, Falchook AD, Basak R, Carpenter WR, Chen RC. Total medicare costs associated with diagnosis and treatment of prostate cancer in elderly men. JAMA Oncol. 2019;5:60–6.

    Article  Google Scholar 

  3. 3.

    Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, et al. Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options. J Urol. 2018;199:683–90.

    Article  Google Scholar 

  4. 4.

    Cookson MS, Roth BJ, Dahm P, Engstrom C, Freedland SJ, Hussain M, et al. Castration-resistant prostate cancer: AUA Guideline. J Urol. 2013;190:429–38.

    Article  Google Scholar 

  5. 5.

    Howlader N, Noone A, Krapcho M, Miller D, Brest A, Yu M et al. SEER cancer statistics review, 1975–2016. Bethesda, MD: National Cancer Institute. Bethesda; 2019.

  6. 6.

    Hu JC, Nguyen P, Mao J, Halpern J, Shoag J, Wright JD, et al. Increase in prostate cancer distant metastases at diagnosis in the United States. JAMA Oncol. 2017;3:705–7.

    Article  Google Scholar 

  7. 7.

    Zavaski ME, Meyer CP, Sammon JD, Hanske J, Gupta S, Sun M, et al. Differences in prostate-specific antigen testing among urologists and primary care physicians following the 2012 USPSTF recommendations. JAMA Intern Med. 2016;176:546–7.

    Article  Google Scholar 

  8. 8.

    Fletcher SA, von Landenberg N, Cole AP, Gild P, Choueiri TK, Lipsitz SR et al. Contemporary national trends in prostate cancer risk profile at diagnosis. Prostate Cancer Prostatic Dis. 2020;23:81–7.

    CAS  Article  Google Scholar 

  9. 9.

    Miller DC, Gust C, Dimick JB, Birkmeyer N, Skinner J, Birkmeyer JD. Large variations in Medicare payments for surgery highlight savings potential from bundled payment programs. Health Aff. 2011;30:2107–15.

    Article  Google Scholar 

  10. 10.

    Bozic KJ, Ward L, Vail TP, Maze M. Bundled payments in total joint arthroplasty: targeting opportunities for quality improvement and cost reduction. Clin Orthop Relat Res®. 2014;472:188–93.

    Article  Google Scholar 

Download references

Funding

Q-DT is supported by the Brigham Research Institute Fund to Sustain Research Excellence, the Bruce A. Beal and Robert L. Beal Surgical Fellowship, the Genentech Bio-Oncology Career Development Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology (grant # 10202), a Health Services Research pilot test grant from the Defense Health Agency, the Clay Hamlin Young Investigator Award from the Prostate Cancer Foundation (grant # 16YOUN20), and an unrestricted educational grant from the Vattikuti Urology Institute.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Quoc-Dien Trinh.

Ethics declarations

Conflict of interest

Q-DT reports consulting fees from Bayer, Astellas, and Janssen. All other authors have nothing to disclose.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

McClintock, T.R., Cone, E.B., Marchese, M. et al. Prostate cancer management costs vary by disease stage at presentation. Prostate Cancer Prostatic Dis (2020). https://doi.org/10.1038/s41391-020-0239-x

Download citation